Stock listing

NASDAQ:IPXL Impax Laboratories Inc Stock

Follow Impax Laboratories Inc into a list and get an email when it puts out news.

Last close · NASDAQ:IPXL

$14.71 USD

Close on May 8, 2018 · No longer trades

Dec 22, 1997 to last close +352.6% · monthly closes, Dec 22, 1997 – May 8, 2018
Lowest – highest close
$1.00 – $51.31 USDSince Dec 22, 1997 · lowest Oct 21, 1998 · highest Apr 15, 2015

Delisted NASDAQ:IPXL no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:IPXL
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Impax Laboratories Inc on 6ix

Decks
35 decks · latest Mar 1, 2018

Decks

DeckKindSlidesDate
Q4 2017 Earnings PresentationEarnings23 slidesMar 1, 2018
J.P. Morgan Global Healthcare Conference 2018Conference19 slidesJan 9, 2018
Q3 2017 Earnings PresentationEarnings22 slidesNov 9, 2017
Merger or Acquisition (October 2017)Merger or acquisition22 slidesOct 17, 2017
Merger or Acquisition (October 2017)Merger or acquisition43 slidesOct 17, 2017
Q2 2017 Earnings PresentationEarnings24 slidesAug 9, 2017
Q1 2017 Earnings PresentationEarnings26 slidesMay 10, 2017
FY2016 Earnings PresentationEarnings24 slidesMar 1, 2017
35th Annual J.P. Morgan Healthcare Conference (January 2017)Conference17 slidesJan 11, 2017
Q3 2016 Earnings PresentationEarnings31 slidesNov 9, 2016
All 35 decks
DeckKindSlidesDate
Q2 2016 Earnings PresentationEarnings28 slidesAug 9, 2016
Merger or Acquisition (June 2016)Merger or acquisition19 slidesJun 21, 2016
Q1 2016 Earnings PresentationEarnings23 slidesMay 10, 2016
Q4 2015 Earnings PresentationEarnings32 slidesFeb 22, 2016
Conference Presentation (January 2016)Conference18 slidesJan 12, 2016
Q3 2015 Earnings PresentationEarnings22 slidesNov 9, 2015
Q2 2015 Earnings PresentationEarnings22 slidesAug 10, 2015
33rd Annual J.P. Morgan Healthcare Conference (January 2015)Conference20 slidesJan 13, 2015
J.P. Morgan Healthcare Conference 2014Conference22 slidesJan 14, 2014
J.P. Morgan Healthcare Conference 2013Conference18 slidesJan 8, 2013
J.P. Morgan Healthcare Conference 2012Conference22 slidesJan 9, 2012
Technical Presentation (March 2011)Technical24 slidesMar 15, 2011
J.P. Morgan Healthcare Conference 2011Conference30 slidesJan 11, 2011
J.P. Morgan Healthcare Conference 2010Conference29 slidesJan 12, 2010
Investor Presentation (May 2008)Investor deck32 slidesMay 15, 2008
Investor Presentation (March 2008)Investor deck34 slidesMar 17, 2008
Investor Presentation (February 2008)Investor deck30 slidesFeb 7, 2008
Investor Presentation (January 2008)Investor deck27 slidesJan 9, 2008
Investor Presentation (November 2007)Investor deck27 slidesNov 13, 2007
Investor Presentation (August 2007)Investor deck30 slidesAug 8, 2007
Investor Presentation (May 2007)Investor deck29 slidesMay 4, 2007
Investor Presentation (March 2007)Investor deck28 slidesMar 20, 2007
Investor Presentation (February 2007)Investor deck29 slidesFeb 7, 2007
Investor Presentation (November 2006)Investor deck29 slidesNov 2, 2006
Investor Presentation (March 2006)Investor deck28 slidesMar 30, 2006

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Paul M. Bisaro
Other companies: Myriad Genetics, Inc. (Director · Since at least Oct 31, 2022); Mallinckrodt Inc (Director · Since at least Jun 16, 2022); Zoetis Inc. (Chairman of the Board · Since at least May 1, 2015); TherapeuticsMD, Inc. (Director · Mar 20, 2020 – Sep 29, 2022 · Past); Amneal Pharmaceuticals, Inc. (Executive Chairman, Director · May 4, 2018 – May 7, 2019 · Past); Zimmer Biomet Holdings, Inc. (Director · Dec 12, 2013 – Mar 31, 2017 · Past)
President and CEO, Director · Mar 27, 2017 – May 4, 2018 · Past
Bryan M Reasons
Other companies: Mallinckrodt Inc (EVP & CFO · Since at least Mar 18, 2019); Amneal Pharmaceuticals, Inc. (CFO · May 4, 2018 – Aug 21, 2018 · Past); Aclaris Therapeutics, Inc. (Director · Apr 20, 2018 – Jun 1, 2024 · Past); Recro Pharma Inc (Director · Mar 3, 2017 – Apr 8, 2024 · Past)
Chief Financial Officer · Apr 13, 2013 – May 4, 2018 · Past
Carole Ben-Maimon
Other companies: Larimar Therapeutics, Inc. (President and CEO, Director · Since at least May 28, 2020); Teligent Inc (Director · Mar 29, 2016 – Jul 21, 2021 · Past)
President, Global Pharm. · Sep 6, 2011 – May 14, 2014 · Past
Douglas Boothe
Other companies: Akorn Inc (President and CEO, Director · Jan 1, 2019 – Jan 8, 2020 · Past)
President, Generics Division · Aug 1, 2016 – May 4, 2018 · Past
Mark A Schlossberg
Other companies: Cytokinetics, Incorporated (SVP - Legal & General Counsel · Jan 14, 2019 – Mar 15, 2022 · Past)
SVP and General Counsel · Feb 26, 2018 – May 4, 2018 · Past
Jeffrey NornholdSVP, Technical Operations · Apr 1, 2014 – May 4, 2018 · Past
Kim Sun OhDirector · Dec 31, 2006 – Nov 11, 2009 · Past
Michael MarkbreiterDirector · Dec 31, 2006 – Aug 28, 2015 · Past
Michael NestorPresident, Impax Specialty · May 20, 2010 – May 4, 2018 · Past
Nigel FlemingDirector · Aug 31, 2015 – Aug 31, 2015 · Past

Open People

Log in to ask 6ix AI your own questions about Impax Laboratories Inc.